|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
|
|---|---|---|---|
| Cash flows from operating activities: | |||
| Net earnings (loss) | |||
| Adjustments to reconcile net earnings (loss) to net cash provided by (used in) operating activities: | |||
| Depreciation and amortization | |||
| Stock-based compensation | |||
| Impairment expense | |||
| Share of (earnings) losses of affiliates, net | |||
| Realized and unrealized (gains) losses on intergroup interests, net | |||
| Realized and unrealized (gains) losses on financial instruments, net | |||
| (Gains) losses on dispositions, net | |||
| Deferred income tax expense (benefit) | |||
| Cash receipts from returns on equity method investments | |||
| Net cash received (paid) for interest rate swaps | |||
| Other charges (credits), net | |||
| Net change in operating assets and liabilities: | |||
| Current and other assets | |||
| Payables and other liabilities | |||
| Net cash provided by (used in) operating activities | |||
| Cash flows from investing activities: | |||
| Capital expended for property and equipment | |||
| Acquisition of real estate assets | |||
| Investments in equity method affiliates and equity securities | |||
| Other investing activities, net | |||
| Net cash provided by (used in) investing activities | |||
| Cash flows from financing activities: | |||
| Borrowings of debt | |||
| Repayments of debt | |||
| Contribution from noncontrolling interest | |||
| Proceeds (disbursements) from exercise of stock options and other stock issuances | |||
| Other financing activities, net | |||
| Net cash provided by (used in) financing activities | |||
| Net increase (decrease) in cash, cash equivalents and restricted cash | |||
| Cash, cash equivalents and restricted cash at beginning of period | |||
| Cash, cash equivalents and restricted cash at end of period |
Loading...
